Anaesthesia and pain
18 results
Applied filters
Levobupivacaine: informing intrathecal risk assessment
19 February 2024Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Morphine: informing intrathecal risk assessment
19 February 2024Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Lidocaine: informing intrathecal risk assessment
19 February 2024Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Phenol: informing intrathecal risk assessment
19 February 2024Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Ropivacaine: informing intrathecal risk assessment
19 February 2024Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Use of nefopam for chronic pain
30 January 2024Nefopam is licensed for chronic pain relief. However, evidence to support use is limited and is not included in national guidelines.
Using strong opioid analgesics during breastfeeding
26 May 2023Morphine is the strong opioid analgesic of choice for treating pain in breastfeeding. Recommendations apply to full term and healthy infants only.
Using gabapentin or pregabalin during breastfeeding
12 April 2023Gabapentin or pregabalin can be taken during breastfeeding and with infant monitoring. Recommendations apply to full term and healthy infants only.